Sinotherapeutics Inc Class A 688247
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 50.29
- Price/Sales
- 9.82
- Dividend Yield (Trailing)
- 0.48%
- Dividend Yield (Forward)
- 0.48%
- Total Yield
- 0.48%
Company Profile
Sinotherapeutics Inc is engaged in the research and development, production and sales of generic drugs and CRO services.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 260
- Website
- http://www.sinotherapeutics.com
Comparables
Valuation
Metric
|
688247
|
300142
|
603896
|
---|---|---|---|
Price/Earnings (Normalized) | 50.29 | 65.42 | 18.81 |
Price/Book Value | 3.20 | 2.07 | 2.05 |
Price/Sales | 9.82 | 5.81 | 5.76 |
Price/Cash Flow | 34.60 | 18.10 | 12.20 |
Price/Earnings
688247
300142
603896
Financial Strength
Metric
|
688247
|
300142
|
603896
|
---|---|---|---|
Quick Ratio | 10.32 | 2.51 | 3.21 |
Current Ratio | 11.70 | 2.94 | 3.70 |
Interest Coverage | 23,590.64 | 24.73 | 16.62 |
Quick Ratio
688247
300142
603896
Profitability
Metric
|
688247
|
300142
|
603896
|
---|---|---|---|
Return on Assets (Normalized) | 5.75% | 1.93% | 7.55% |
Return on Equity (Normalized) | 6.52% | 3.16% | 11.00% |
Return on Invested Capital (Normalized) | 6.23% | 2.01% | 7.10% |
Return on Assets
688247
300142
603896
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Zoetis Inc Class A
ZTS
| Hftclzzcy | Lgb | $88.3 Bil | |||
Merck KGaA ADR
MKKGY
| Wrmpymqc | Zqrqjp | $78.0 Bil | |||
Haleon PLC ADR
HLN
| Fgtsglnjx | Ypjlj | $48.4 Bil | |||
Viatris Inc
VTRS
| Pwftrdcn | Zdqc | $13.8 Bil | |||
Dr Reddy's Laboratories Ltd ADR
RDY
| Bhgvwgky | Tnh | $13.5 Bil | |||
Catalent Inc
CTLT
| Vfyxncpst | Jgnmyh | $10.9 Bil | |||
Prestige Consumer Healthcare Inc
PBH
| Tdgbgwld | Wdksckb | $3.5 Bil | |||
Perrigo Co PLC
PRGO
| Qxsbktfq | Vxsjl | $3.5 Bil | |||
Green Thumb Industries Inc
GTBIF
| Jplrcgxwv | Gzbml | $2.5 Bil | |||
Curaleaf Holdings Inc
CURLF
| Pchykwjf | Mfjz | $2.3 Bil |